International Edition
Latest News
Health

The State of Rio de Janeiro Has Confirmed the Country’s First Death From Measles

The state of Rio de Janeiro has confirmed the country's first death from measles. The infectious disease causes skin lesions, mucous membrane sores, fever, headaches, and body aches. State health authorities registered 382 mpox cases in 2026 up…

The State of Rio de Janeiro Has Confirmed the Country's First Death From Measles

The state of Rio de Janeiro has confirmed the country’s first death from measles. The infectious disease causes skin lesions, mucous membrane sores, fever, headaches, and body aches.

State health authorities registered 382 mpox cases in 2026 up to December 13. Between January 1 and September 12, officials recorded 124 infections. Following that period, the state registered another 258 cases.

Confirmation rates surged from 23.6% in the initial period to 49.5% afterward. At least 55 patients required hospitalization. The average age of infected individuals stands at 33.8 years, with the city of Rio de Janeiro concentrating 71.2% of all state records.

Ministry of Health secures 25 million mpox vaccine doses

The Ministry of Health secured 25 mil doses of the mpox vaccine following negotiations with the Danish manufacturer, as reported by the Federal Government. Through the Pan American Health Organization revolving fund, the ministry expanded an initial 20 mil-dose offer by 5 mil units, with delivery expected within three weeks.

The State of Rio de Janeiro Has Confirmed the Country's First Death From Measles
Photo: Governo Federal

Global vaccine supplies face severe shortages because a single manufacturer in Denmark produces the World Health Organization-prequalified immunization. The national strategic stockpile has already supplied 3,650 doses to nine federative units, including Rio de Janeiro, Ceará, and the Federal District.

To stretch available supplies, the ministry issued a technical note advising states and municipalities to use intradermal administration. This method expands the number of vaccinated individuals up to fivefold per dose for specific groups.

Brazil confirms first mpox death in 2026 in Rio de Janeiro — SBT Jornalismo

Federal Prosecutors Investigate Distribution

The Federal Public Ministry opened a civil inquiry to examine potential omissions by the Ministry of Health regarding vaccine acquisition and distribution, according to the Federal Public Prosecutor’s Office. The investigation follows reports of public network shortages during rising case numbers.

Data cited by federal prosecutor Lucas Costa Almeida Dias showed 665 confirmed cases nationwide by November 4. In Rio de Janeiro, case numbers exceeded the total for 2025 by 77%. The Federal District suspended vaccination on November 3 due to empty stocks, prompting a ministry purchase authorization two days later.

Prosecutors requested information regarding acquisition amounts, distribution criteria, state replenishment requests, and technical justifications for prioritizing individuals living with HIV who have CD4 counts below 100 cells per cubic millimeter.

The State of Rio de Janeiro Has Confirmed the Country's First Death From Measles
Photo: Ministério Público Federal

What are the primary symptoms and vaccination guidelines?

What are the primary symptoms of mpox?

The viral disease causes skin lesions and mucosal sores accompanied by fever, headaches, and body aches. The average age of patients infected during the 2026 outbreak in Rio de Janeiro is 33.8 years.

How is the vaccine administered under current guidelines?

The Ministry of Health recommends intradermal application to stretch limited supplies from the sole manufacturer in Denmark. The two-dose regimen requires a 28-day interval, and shots are administered at Reference Immunization Centers rather than basic health units.

Who qualifies for priority vaccination in Brazil?

The Unified Health System does not perform mass vaccination, targeting instead high-risk groups and individuals with medium- or high-risk exposure to confirmed cases. Priority criteria include individuals living with HIV who show a CD4 cell count below 100 cells per cubic millimeter.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”